entertainment -WSS

entertainment

author：Wikipedia 2025-08-10 11:42:47 - browse：7674

DENVER — He could have been a rock star, a religious icon, the way ecstatic applause from thousands of attendees greeted the man dressed in a crisp, all-white suit as he strode onto a backlit stage. He was neither. This was Rick Doblin, the founder and evangelist of a movement to legalize psychedelic MDMA and bring the drug into mainstream medicine.

The scene in a Denver conference hall last week was a world away from the first conference Multidisciplinary Association for Psychedelic Studies (MAPS) held in 1990, when Doblin spoke alongside Timothy Leary — the ex-Harvard professor who popularized the phrase “turn on, tune in, and drop out.” That was just a few years after MDMA, also known as ecstasy, was criminalized, deemed a Schedule 1 drug “of no medical use.”

Now, as MAPS nears its goal of winning Food and Drug Administration approval for MDMA as a treatment for post-traumatic stress disorder, the perpetually smiling and energetic Doblin is basking in the adoration from both legions of “psychonauts” and unlikely yet powerful allies. “I literally love Rick Doblin,” the conservative Republican and former Texas governor Rick Perry told the audience in Denver.

It was a seemingly triumphant occasion. But even as Doblin is in sniffing distance of his lifelong quest, his once counter-cultural organization is grappling with the pressures of having to operate in the capitalist pharmaceutical sphere. MAPS was founded in 1986 as a nonprofit with deep-seated ideals. Doblin developed an “anti-patent” strategy, putting discoveries in the public domain so they couldn’t be claimed as intellectual property. He raised money to fund clinical trials of MDMA from like-minded wealthy donors.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： Listen: A conversation with researcher Kevin Esvelt on biosecurity

focus

WSS

Reports of telehealth's death have been greatly exaggerated

Fentanyl is making it harder to start addiction treatment

Obesity drug from Roche shows promise in early study

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

CVS is willing to dump 10% of its Medicare Advantage members

Why H5N1 bird flu is keeping the CDC's top flu scientist awake

leisure time

entertainment

Wikipedia

The high cost of giving birth even with insurance

Biogen joins immunology wave with $1.15 billion acquisition of HI

Moonlake's readout produced a cash windfall. Risks remain

Galapagos to make CAR

Dobbs anniversary: the lost opportunity of abortion as health care

Galapagos to make CAR

Guidelines to prevent youth baseball injuries need more muscle

Questions and answers about ramping up H5N1 bird flu vaccine

Heart attack and stroke risk calculators need revising

As H5N1 spreads in cows, experts warn against drinking raw milk

hotspot

Hottest summer in 2,000 years puts focus on extreme heat, health

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

Listen: More tumult at BIO & coercive care for sickle cell patients

Free medical tuition alone isn't enough to close gaps in primary care

Cherokee Nation medical school graduates its first class

Scrutiny of post

focus

knowledge

explore

hotspot